Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-9-14
pubmed:abstractText
Mesothelin is a promising candidate for tumor-specific therapy because of its limited expression in normal tissues and high expression in several cancers. The expression of the protein mesothelin in hematological malignancies has not yet been analyzed. SS1(dsFv)PE38 is a recombinant anti-mesothelin immunotoxin which is undergoing clinical evaluation in patients with mesothelin-expressing tumors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0902-4441
pubmed:author
pubmed:issnType
Print
pubmed:volume
79
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
281-6
pubmed:dateRevised
2011-10-26
pubmed:meshHeading
pubmed-meshheading:17803679-Adolescent, pubmed-meshheading:17803679-Antibodies, Monoclonal, pubmed-meshheading:17803679-Blotting, Western, pubmed-meshheading:17803679-Child, pubmed-meshheading:17803679-Child, Preschool, pubmed-meshheading:17803679-Drug Delivery Systems, pubmed-meshheading:17803679-Drug Resistance, Neoplasm, pubmed-meshheading:17803679-Drug Screening Assays, Antitumor, pubmed-meshheading:17803679-Female, pubmed-meshheading:17803679-GPI-Linked Proteins, pubmed-meshheading:17803679-Gene Expression Regulation, Leukemic, pubmed-meshheading:17803679-Humans, pubmed-meshheading:17803679-Immunohistochemistry, pubmed-meshheading:17803679-Immunotherapy, pubmed-meshheading:17803679-Immunotoxins, pubmed-meshheading:17803679-Infant, pubmed-meshheading:17803679-Leukemia, Myeloid, Acute, pubmed-meshheading:17803679-Male, pubmed-meshheading:17803679-Membrane Glycoproteins, pubmed-meshheading:17803679-Neoplasm Proteins, pubmed-meshheading:17803679-Reverse Transcriptase Polymerase Chain Reaction
pubmed:year
2007
pubmed:articleTitle
Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells.
pubmed:affiliation
University Children's Hospital Jena, Germany. Daniel@Steinba.ch
pubmed:publicationType
Journal Article